| For: | Ramakrishnan P, Garg N, Pabich S, Mandelbrot DA, Swanson KJ. Sodium-glucose cotransporter-2 inhibitor use in kidney transplant recipients. World J Transplant 2023; 13(5): 239-249 [PMID: 37746038 DOI: 10.5500/wjt.v13.i5.239] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v13/i5/239.htm |
| Number | Citing Articles |
| 1 |
Sabaa Asif, Christie Rampersad, Ani Orchanian-Cheff, S. Joseph Kim. Impact of donor-recipient size mismatch on post-transplant outcomes in kidney transplant recipients: A systematic review. Transplantation Reviews 2025; 39(4) doi: 10.1016/j.trre.2025.100965
|
| 2 |
Marcin Adamczak, Ilona Kurnatowska, Beata Naumnik, Tomasz Stompór, Leszek Tylicki, Magdalena Krajewska. Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus—Clinical Practice Position Statement of the Polish Society of Nephrology. International Journal of Molecular Sciences 2024; 25(23) doi: 10.3390/ijms252312941
|
| 3 |
Song C. Ong, Bruce A. Julian. Post-transplant IgA Nephropathy. Seminars in Nephrology 2024; 44(5) doi: 10.1016/j.semnephrol.2025.151570
|
| 4 |
Mehmet Emin Demir, Özant Helvacı, Tolga Yıldırım, Özgür Merhametsiz, Siren Sezer. Potential Role of SGLT‐2 Inhibitors in Improving Allograft Function and Reducing Rejection in Kidney Transplantation. Clinical Transplantation 2025; 39(9) doi: 10.1111/ctr.70233
|
| 5 |
Alishba Khan, Muhammad Mohsin Ali, Rizwan Hamer. Expanding the Therapeutic Landscape: Sodium-Glucose Co-transporter 2 Inhibitors in Kidney Transplant Recipients. Cureus 2025; doi: 10.7759/cureus.97193
|
| 6 |
Inès Dufour, Elliott Van Regemorter, Nada Kanaan, Antoine Buemi, Tom Darius, Michel Mourad, Eric Goffin, Michel Jadoul, Arnaud Devresse, Valentine Gillion. Bridging the Gap Between CKD Management Paradigms in Transplant and Nontransplant Settings: Published Evidence, Challenges, and Perspectives. Transplantation 2025; 109(4) doi: 10.1097/TP.0000000000005186
|
| 7 |
Amin Roshdy Soliman, Mohamed Elkhatib, Sahier El-Khashab, Rasha Ahmed Darwish, Ahmed Fayed, Tarek S. Abdelaziz, Hany Hammad, Rabab Mahmoud Ahmed, Hoda Abdelhamid Maamoun. Dual-faced guardians: SGLT2 inhibitors’ kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG). Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01790-w
|
| 8 |
Amanda J. Vinson, Arthur Matas. Late Allograft Loss and Contemporary Cardiorenal Metabolic Therapies. Journal of the American Society of Nephrology 2025; 36(8) doi: 10.1681/ASN.0000000726
|
| 9 |
Gabriel C. Barsotti, Madhav C. Menon, Abhijit Naik, Arundati Rao. Mechanisms of Podocyte Injury in Kidney Allografts. Kidney360 2026; 7(6) doi: 10.34067/KID.0000001091
|
| 10 |
Aina Quilis, Eva Gavela, Julia Kánter, Cristina Castro-Alonso, Emma Calatayud, Elena Vivó, Manuel Parra, Paula Gandia, Asunción Sancho. Use of SGLT2i in Non-Diabetic Kidney Transplant Recipients. Transplantation Proceedings 2025; 57(1) doi: 10.1016/j.transproceed.2024.12.009
|
| 11 |
Kurtis J. Swanson, Fahad Aziz, Sandesh Parajuli. Proteinuria after Kidney Transplantation: Evaluation and Management. Current Transplantation Reports 2026; 13(1) doi: 10.1007/s40472-026-00521-y
|